secwatch.observer — SEC 8-K summary
======================================

Issuer:     CODEXIS, INC. (CDXS)
CIK:        0001200375
Form:       8-K
Filed at:   2024-11-12T23:59:59+00:00
Accession:  0001193125-24-255904
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Codexis appoints Raymond De Vré to Board; adopts amended bylaws
---------------------------------------------------------------

- Raymond De Vré appointed as Class I director effective Nov 7, 2024; term expires at 2026 annual meeting.
- De Vré, former CEO of PolyPeptide Group and ex-McKinsey partner, joins Science and Technology Committee.
- Initial RSU grant of $200,000 (47,847 shares at $4.18 close); annual cash retainer $50,000 plus $10,000 committee retainer.
- Bylaws amended to align with Delaware law, update stockholder nomination/proposal procedures, and meeting conduct rules.
- No material financial impact; routine governance changes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1200375/000119312524255904/0001193125-24-255904-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1200375/000119312524255904/d892460d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-255904

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer